Pfizer Inc (PFE)
27.82
+0.12
(+0.43%)
USD |
NYSE |
May 03, 16:00
27.86
+0.04
(+0.14%)
After-Hours: 20:00
Pfizer Price to Book Value: 1.770 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.762 |
| May 01, 2024 | 1.729 |
| April 30, 2024 | 1.630 |
| April 29, 2024 | 1.631 |
| April 26, 2024 | 1.616 |
| April 25, 2024 | 1.607 |
| April 24, 2024 | 1.671 |
| April 23, 2024 | 1.674 |
| April 22, 2024 | 1.670 |
| April 19, 2024 | 1.654 |
| April 18, 2024 | 1.615 |
| April 17, 2024 | 1.617 |
| April 16, 2024 | 1.634 |
| April 15, 2024 | 1.648 |
| April 12, 2024 | 1.645 |
| April 11, 2024 | 1.676 |
| April 10, 2024 | 1.674 |
| April 09, 2024 | 1.704 |
| April 08, 2024 | 1.691 |
| April 05, 2024 | 1.696 |
| April 04, 2024 | 1.695 |
| April 03, 2024 | 1.732 |
| April 02, 2024 | 1.753 |
| April 01, 2024 | 1.763 |
| March 31, 2024 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.765 |
| March 27, 2024 | 1.767 |
| March 26, 2024 | 1.755 |
| March 25, 2024 | 1.745 |
| March 22, 2024 | 1.740 |
| March 21, 2024 | 1.760 |
| March 20, 2024 | 1.762 |
| March 19, 2024 | 1.758 |
| March 18, 2024 | 1.763 |
| March 15, 2024 | 1.777 |
| March 14, 2024 | 1.790 |
| March 13, 2024 | 1.795 |
| March 12, 2024 | 1.782 |
| March 11, 2024 | 1.805 |
| March 08, 2024 | 1.732 |
| March 07, 2024 | 1.704 |
| March 06, 2024 | 1.730 |
| March 05, 2024 | 1.659 |
| March 04, 2024 | 1.647 |
| March 01, 2024 | 1.692 |
| February 29, 2024 | 1.690 |
| February 28, 2024 | 1.720 |
| February 27, 2024 | 1.706 |
| February 26, 2024 | 1.724 |
| February 23, 2024 | 1.761 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.522
Minimum
Dec 14 2023
4.542
Maximum
Dec 16 2021
2.924
Average
3.067
Median
Apr 28 2020
Price to Book Value Benchmarks
| Amgen Inc | 26.78 |
| Johnson & Johnson | 5.133 |
| Eli Lilly and Co | 54.56 |
| Viking Therapeutics Inc | 9.086 |
| Moderna Inc | 3.454 |
Price to Book Value Related Metrics
| PS Ratio | 2.866 |
| Price | 27.82 |
| Earnings Yield | -0.22% |
| Market Cap | 157.53B |
| Operating PE Ratio | 132.46 |
| Normalized PE Ratio | 46.47 |